Pfizer-allied molecular glue startup Triana collects $120M Series Bnews2025-12-03T15:28:30+00:00December 3rd, 2025|Endpoints News|
Excelsior Sciences raises $95M for small molecule drug discovery, manufacturingnews2025-12-03T13:00:11+00:00December 3rd, 2025|Endpoints News|
Bristol Myers pushes back Cobenfy readout after trial site ‘irregularities’news2025-12-03T12:41:17+00:00December 3rd, 2025|Endpoints News|
Updated: Pharvaris’ hereditary angioedema drug gets Phase 3 winnews2025-12-03T12:20:48+00:00December 3rd, 2025|Endpoints News|
Cosmo Pharmaceuticals’ shares rise after Phase 3 win in male pattern hair lossnews2025-12-03T12:11:32+00:00December 3rd, 2025|Endpoints News|
Hospitals challenge 340B rebate pilot program in Maine federal courtnews2025-12-02T20:24:15+00:00December 2nd, 2025|Endpoints News|
Pentagon seeks to add WuXi AppTec to military list: reportnews2025-12-02T20:19:07+00:00December 2nd, 2025|Endpoints News|
New York judge revives Bristol Myers dispute over Celgene dealnews2025-12-02T20:12:11+00:00December 2nd, 2025|Endpoints News|
FDA to remove some monkey testing from monoclonal antibody developmentnews2025-12-02T19:42:33+00:00December 2nd, 2025|Endpoints News|
Tech emerges as a new frontier for digital therapeuticsnews2025-12-02T17:31:42+00:00December 2nd, 2025|Endpoints News|
